Proliferating cell nuclear antigen (PCNA) expression in pseudoepitheliomatous hyperplasia, keratoacanthoma and squamous cell carcinoma of the skin

Annals of the Academy of Medicine Singapore

Volumn 25, Issue 4, 1996, Pages 526-530

  Li, J ^a   Lee, Y S ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Biological behaviour; Epidermoproliferative lesions; Neoplasms; Proliferative index

Indexed keywords

CYCLINE;

ARTICLE; BOWEN DISEASE; EPITHELIUM; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; METABOLISM; PATHOLOGY; SKIN DISEASE; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

BOWEN'S DISEASE; CARCINOMA, SQUAMOUS CELL; EPITHELIUM; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; PROLIFERATING CELL NUCLEAR ANTIGEN; SKIN DISEASES; SKIN NEOPLASMS;

EID: 0030179547     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bravo R, Frank R, Blundell P A, Macdonald-Bravo H Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987a; 326:515-7
2. Prelich G, Tan C K, Kostura M, Mathews M B, So A G, Downey K M, et al. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 1987; 326:517-20.
3. Morris G F, Mathews M B Regulation of proliferating cell nuclear antigen during cell cycle. J Biol Chem 1989; 264:13858-64.
4. Saida T, Dohi S, Sadaki M, Tokuda Y, Ikegawa S, Takasaki Y. Distribution patterns and frequency of proliferating cells in cutaneous keratinocytic neoplasms - Immunohistochemical study with a monoclonal antibody (TOB7) used against proliferating cell nuclear antigen. J Am Acad Dermatol 1992; 26:744-8.
5. Rieger E, Wellenhof R H, Soyer H P, Kofler R, Cerroni L, Smolle J, et al. Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. J Cutan Pathol 1992; 20:229-36.
6. Niemann T H, Argenyi Z B. Immunohistochemical study of spitz nevi and malignant melanoma with use of antibody to proliferating cell nuclear antigen. Am J Dermatopathol 1993; 15:441-5
7. Geary W A, Cooper P H. Proliferating cell nuclear antigen (PCNA) in common epidermal lesions. J Cutan Pathol 1992; 19.458-68
8. Penneys N S, Bogaert M, Serfling U, Sisto M. PCNA expression in cutaneous keratinous neoplasms and verruca vulgaris Am J Pathol 1992; 141:139-42
9. Kanitakis J, Hoyo E, Chouvet B, Thivolet J, Faure M, Claudy A. Keratinocyte proliferation in epidermal keratinocyte disorders evaluated through PCNA/cyclin immunolabelling and AgNOR counting. Acta Derm Venereol (Stockh) 1993; 73:370-5.
10. Phillips P, Helm K F. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma. J Cutan Pathol 1993, 20.424-8.
11. Lever W F, Schaumberg-Iever G. Histopathology of the Skin 7th ed. Philadelphia, Pa: J B Lippincott, 1990:552-63.
12. Hodak E, Jones R E, Ackerman A B. Solitary keratoacanthoma is a squamous-cell carcinoma three examples with metastases. Am J Dermatopathol 1993; 15:332-42.
13. Schwarts R A Keratoacanthoma J Am Acad Dermatol 1994, 30:1-19.
14. Broders A C. Squamous cell epithelioma of the skin. Ann Surg 1921; 73 141-60.
15. Bangham A D, Horne R W. Action of saponin on biological cell membranes. Nature 1962; 196:952-5.
16. Lee J. Graphical presentation of the confidence interval of the mean and binomial proportion. J Med Lab Sci 1993; 7:84-7.
17. Ojanguren I, Ariza A, Llatjos M, Castella E, Mate J L, Navas-palacios J J. Proliferating cell nuclear antigen expression in normal, regenerative, and neoplastic liver: A fine-needle aspiration cytology and biopsy study. Hum Pathol 1993; 24:905-8.
18. Maeda K, Chung Y S, Onoda N, Kato Y, Nitta A, Arimoto Y, et al. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis. Cancer 1994; 73:528-33.
19. Yu CCW, Filipe MI. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications Histochem J 1993; 25:843-53.
20. Jain S, Filipe M I, Hall P A, Waseem N, Lane D P, Levison D A. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 1991; 44:655-9.
21. Lavker R M, Sun T T. Epidermal stem cells. J Invest Dermatol 1983; 81 121s-7s.
22. Bravo R, Macdonald-Bravo H. Existence of two populations of cyclin/ proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 1987b; 105:1549-54.
23. Ng I O L, Lai E C S, Fan S T, Ng M, Chan A S Y, So M K P. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 1994, 73:2268-74.
24. Arnold H L, Odom R B, James W D. Andrews' diseases of the skin. Clinical Dermatology. 8th ed. Philadelphia: W B Saunders, 1990:754-6, 777-80.
25. Grussendorf-Conen E I, Giesen M. Papillomavirus common antigen in Bowen's disease. Dermatologica 1990; 181:11-5.
26. 2'6. Niimura M. Skin cancer and virus. Hum Cell 1992; 5:160-6.
27. Steinmann K E, Xu F P, Stoppler H, Schlegel R, Schlegel R. Elevated expression and activity of mitotic regulatory proteins in human papillomavirus-immortalized keratinocytes. Oncogene 1994; 9:387-94.
28. Vogelstein B, Kinzler K W. The multistep nature of cancer Trends Genet 1993, 9:138-41.
29. Nowell P C. The clonal expression of tumor cell populations. Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression Science 1976; 194:23-8.